HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo Puoti Selected Research

Hepatitis B

10/2017Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis.
1/2016Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection.
5/2014Management of infections pre- and post-liver transplantation: report of an AISF consensus conference.
12/2008Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study.
3/2007Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
1/2002Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimo Puoti Research Topics

Disease

47Infections
12/2023 - 01/2002
34Coinfection
12/2023 - 01/2002
28Fibrosis (Cirrhosis)
11/2023 - 08/2002
19COVID-19
11/2023 - 08/2020
18Liver Diseases (Liver Disease)
12/2023 - 07/2005
16Chronic Hepatitis C
01/2022 - 08/2002
15Hepatitis C
12/2022 - 07/2002
10Liver Cirrhosis (Hepatic Cirrhosis)
12/2023 - 01/2004
10Hepatitis
01/2022 - 08/2002
8HIV Infections (HIV Infection)
05/2020 - 01/2008
7Pneumonia (Pneumonitis)
10/2023 - 02/2018
6Hepatitis B
10/2017 - 01/2002
4Disease Progression
10/2023 - 07/2002
3Reinfection
10/2023 - 01/2017
3End Stage Liver Disease
01/2023 - 07/2002
3Acquired Immunodeficiency Syndrome (AIDS)
01/2021 - 01/2011
2Inflammation (Inflammations)
11/2023 - 07/2015
2Breakthrough Infections
11/2023 - 12/2021
2Multiple Sclerosis
10/2023 - 01/2021
2Respiratory Insufficiency (Respiratory Failure)
10/2023 - 11/2021
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2023 - 01/2018
2Hepatocellular Carcinoma (Hepatoma)
01/2023 - 04/2011
2Vasculitis (Vasculitides)
01/2022 - 06/2011
2Diabetes Mellitus
12/2021 - 01/2016
2Cardiovascular Diseases (Cardiovascular Disease)
07/2021 - 09/2015
2Viremia
02/2021 - 06/2005
2Bacterial Infections (Bacterial Infection)
11/2020 - 12/2014
2Rheumatoid Arthritis
11/2019 - 01/2016
2Neoplasms (Cancer)
10/2018 - 01/2018
2Virus Diseases (Viral Diseases)
01/2018 - 01/2017
2Persistent Infection
10/2015 - 11/2002
2Insulin Resistance
07/2015 - 04/2008
2Communicable Diseases (Infectious Diseases)
05/2014 - 08/2012
2Chronic Hepatitis B
02/2006 - 01/2006
1Central Nervous System Infections (Central Nervous System Infection)
04/2024
1Meningitis
04/2024
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2024
1Mycoses (Diseases, Fungus)
01/2024
1Fever (Fevers)
01/2024
1Hematologic Neoplasms (Hematological Malignancy)
01/2024
1Prostatitis
12/2023
1Urinary Tract Infections (Urinary Tract Infection)
12/2023

Drug/Important Bio-Agent (IBA)

26Antiviral Agents (Antivirals)IBA
01/2023 - 08/2004
23Ribavirin (Virazole)FDA LinkGeneric
11/2018 - 08/2002
18RNA (Ribonucleic Acid)IBA
12/2023 - 01/2008
16InterferonsIBA
01/2018 - 01/2002
7SofosbuvirIBA
12/2019 - 05/2014
6glecaprevir and pibrentasvirIBA
05/2021 - 01/2018
6Ritonavir (Norvir)FDA Link
10/2020 - 07/2014
5Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2023 - 06/2009
4VaccinesIBA
11/2023 - 05/2014
4tocilizumab (atlizumab)FDA Link
01/2021 - 08/2020
4paritaprevirIBA
11/2018 - 01/2017
4ombitasvirIBA
11/2018 - 01/2017
4dasabuvirIBA
11/2018 - 01/2017
4EnzymesIBA
07/2014 - 07/2005
3Anti-Bacterial Agents (Antibiotics)IBA
12/2023 - 02/2018
3Immunoglobulin G (IgG)IBA
11/2023 - 01/2017
3Alanine Transaminase (SGPT)IBA
01/2019 - 02/2006
3daclatasvirIBA
01/2019 - 01/2017
3Transaminases (Aminotransferases)IBA
05/2016 - 01/2007
3DNA (Deoxyribonucleic Acid)IBA
01/2016 - 04/2011
3N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
09/2015 - 09/2013
3telaprevirIBA
09/2015 - 09/2013
3LipidsIBA
01/2006 - 03/2002
2carbapenemaseIBA
04/2024 - 01/2021
2Carbapenems (Carbapenem Antibiotics)IBA
04/2024 - 06/2022
2AlbuminsIBA
11/2023 - 10/2018
2Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2023
2cilgavimabIBA
10/2023 - 05/2023
2Rituximab (Mabthera)FDA Link
10/2023 - 06/2011
2tixagevimabIBA
10/2023 - 05/2023
2Oxygen (Dioxygen)IBA
11/2021 - 01/2021
2AntigensIBA
01/2021 - 01/2021
2Immunosuppressive Agents (Immunosuppressants)IBA
10/2018 - 05/2014
2pibrentasvirIBA
01/2018 - 01/2018
2glecaprevirIBA
01/2018 - 01/2018
2sofosbuvir drug combination ledipasvirIBA
12/2016 - 05/2014
2Triglycerides (Triacylglycerol)IBA
01/2016 - 11/2002
2Anti-Retroviral Agents (Antiretroviral Agents)IBA
10/2015 - 07/2015
2lipoarabinomannan (LAM)IBA
04/2013 - 06/2009
2Lamivudine (Epivir)FDA Link
06/2009 - 01/2006
1meropenem and vaborbactamIBA
04/2024
1Interleukin-6 (Interleukin 6)IBA
11/2023
1mRNA VaccinesIBA
11/2023

Therapy/Procedure

42Therapeutics
10/2023 - 01/2002
11Highly Active Antiretroviral Therapy (HAART)
01/2015 - 01/2002
10Liver Transplantation
11/2023 - 07/2002
5Kidney Transplantation
10/2020 - 10/2018
4Duration of Therapy
12/2019 - 11/2013
4Renal Dialysis (Hemodialysis)
02/2019 - 10/2018
3Opiate Substitution Treatment
10/2020 - 12/2016
2Drug Therapy (Chemotherapy)
01/2024 - 01/2018
2Transplantation
12/2023 - 05/2014
2Drug Prescriptions
01/2023 - 08/2011
2Aftercare (After-Treatment)
12/2022 - 01/2021
2Length of Stay
11/2020 - 02/2018
2Drug Tapering
05/2016 - 01/2015
1Remission Induction
01/2024
1Hematopoietic Stem Cell Transplantation
01/2024